Philippe Matthews Show Guru Advice, Author Reviews, Tech Reviews, Entertainment News

A radical new way of making structures visible at the nano level has been developed at Johannes Gutenberg University Mainz (JGU, Germany).

The treatment of hepatitis C virus infections has taken a major step forward with the U.S. Food and Drug Administration’s approval of two new drugs, telaprevir and boceprevir, for managing the disease.

By Amber Dance of Nature magazine Those wanting to raise awareness about a rare disease will be able to take advantage of an initiative being launched later this year: a website that connects research projects with members of the public who can donate just a few dollars to help to develop cures. The plan, called the Global Genes Fund, will "democratize the research proposal game", says Irwin Feller, an emeritus professor of the economics of science and technology at Pennsylvania State University in University Park. The idea has been developed by the Children's Rare Disease Network, a non-profit organization based in Dana Point, California.